COMP <GO>
REPL vs NVAX // EV/EBITDA & P/E VALUATION
Replimune Group Inc. (NASDAQ) VS. Novavax Inc. (NASDAQ) • 15-METRIC TALLY: REPL 1
— NVAX 4
■ METRIC PARITY
LAST: $17.39 (+8.28%) • MKT CAP: $1.65B
valuation
—
LAST: $10.47 (+1.45%) • MKT CAP: $1.73B
valuation
3.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (REPL VS. NVAX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | REPL | NVAX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 93.50% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 85.00% | -120.00 | NVAX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 3.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -17.01% | -14.17% | -2.84 | NVAX | /fcf-yield <GO> |
| Operating Margin | — | 40.30% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 39.20% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 64.70% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | NVAX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 75.1 | 44.9 | +30.23 | REPL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 3.5x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.65B | $1.73B | -$78.4M | NVAX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | REPL REV | NVAX REV | REPL GROSS % | NVAX GROSS % | REPL FCF | NVAX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $1.12B | — | 93.5% | -$280.3M | -$244.6M |
| FY 2024 | $0 | $682.2M | — | 70.3% | -$192.3M | -$87.3M |
| FY 2023 | $0 | $983.7M | — | — | -$185.5M | -$714.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
REPL // BETA —
NVAX // BETA —